According to one study in breast cancer patients, based on the expression of specific markers CD29, FAP, FSP1, α-SMA, CAV-1 and dipeptidylpeptidase 4 (DPP-4, CD26), CAFs can be classified into four subtypes: CAFs-S1 to S4 [102]. This evidence concerns the gene ACTA1 and breast carcinoma.